Product Information
COPAXONE 20 MG/ML SYRINGE is a brand product labeled by Teva Neuroscience, Inc., priced at $230.1972 per ML under NDC 68546031730. Its NADAC has been published 554 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Glatiramer Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
Teva Neuroscience, Inc.NDC
68546031730
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020622On Market Since
4/28/2008
Price Statistics
The NADAC for COPAXONE 20 MG/ML SYRINGE has been published 554 times since Nov 28, 2013, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $230.1972 per ML |
|---|---|
| All-time high | $5406.0222 (Sep 24, 2014) |
| All-time low | $178.6547 (Dec 17, 2014) |
| 52-week high | $230.1972 |
| 52-week low | $228.9944 |
| Median price | $230.0512 |
| Average price | $595.5329 |
| Largest weekly change | -96.7% (Nov 19, 2014) |
| Weeks tracked | 554 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of COPAXONE 20 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for COPAXONE 20 MG/ML SYRINGE, manufactured by Teva Neuroscience, Inc., is $230.1972 per ML (NDC 68546031730), effective Jun 24, 2026.
How has the price of COPAXONE 20 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for COPAXONE 20 MG/ML SYRINGE has declined 94.9%. It has been tracked across 554 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COPAXONE 20 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for COPAXONE 20 MG/ML SYRINGE has ranged from a low of $178.6547 (Dec 17, 2014) to a high of $5406.0222 (Sep 24, 2014), with a median of $230.0512 per ML.
Are there cheaper alternatives to COPAXONE 20 MG/ML SYRINGE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GLATOPA 20 MG/ML SYRINGE, is $45.7269 per ML — about 80% below COPAXONE 20 MG/ML SYRINGE.
Who manufactures COPAXONE 20 MG/ML SYRINGE?
COPAXONE 20 MG/ML SYRINGE (NDC 68546031730) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification